• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

缺乏呋塞米反应预测肝移植后严重急性肾损伤。

Lack of furosemide responsiveness predict severe acute kidney injury after liver transplantation.

机构信息

Department of Transplantation, The Third Xiangya Hospital, Central South University, Changsha, China.

Engineering and Technology Research Center for Transplantation Medicine of National Health Comission, The Third Xiangya Hospital, Central South University, Changsha, China.

出版信息

Sci Rep. 2023 Mar 27;13(1):4978. doi: 10.1038/s41598-023-31757-8.

DOI:10.1038/s41598-023-31757-8
PMID:36973328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10042839/
Abstract

Acute kidney injury (AKI) remains to be a common but severe complication after liver transplantation (LT). However, there are still few clinically validated biomarkers. A total of 214 patients who underwent routine furosemide (1-2 mg/kg) after LT were retrospectively included. The urine output during the first 6 h was recorded to evaluate the predictive value of AKI stage 3 and renal replacement therapy (RRT). 105 (49.07%) patients developed AKI, including 21 (9.81%) progression to AKI stage 3 and 10 (4.67%) requiring RRT. The urine output decreased with the increasing severity of AKI. The urine output of AKI stage 3 did not significantly increase after the use of furosemide. The area under the receiver operator characteristic (ROC) curves for the total urine output in the first hour to predict progression to AKI stage 3 was 0.94 (p < 0.001). The ideal cutoff for predicting AKI progression during the first hour was a urine volume of less than 200 ml with a sensitivity of 90.48% and specificity of 86.53%. The area under the ROC curves for the total urine output in the six hours to predict progression to RRT was 0.944 (p < 0.001). The ideal cutoff was a urine volume of less than 500 ml with a sensitivity of 90% and specificity of 90.91%. Severe AKI after liver transplantation seriously affects the outcome of patients. Lack of furosemide responsiveness quickly and accurately predict AKI stage 3, and patients requiring RRT after the operation.

摘要

急性肾损伤(AKI)仍然是肝移植(LT)后常见但严重的并发症。然而,目前仍然缺乏临床验证的生物标志物。回顾性纳入了 214 例 LT 后常规使用呋塞米(1-2mg/kg)的患者。记录术后 6 小时内的尿量,以评估 AKI 3 期和肾脏替代治疗(RRT)的预测价值。105 例(49.07%)患者发生 AKI,其中 21 例(9.81%)进展为 AKI 3 期,10 例(4.67%)需要 RRT。随着 AKI 严重程度的增加,尿量减少。AKI 3 期患者使用呋塞米后尿量无明显增加。第一个小时总尿量预测 AKI 3 期进展的受试者工作特征(ROC)曲线下面积为 0.94(p<0.001)。第一个小时预测 AKI 进展的理想截点为尿量少于 200ml,灵敏度为 90.48%,特异性为 86.53%。6 小时总尿量预测 RRT 进展的 ROC 曲线下面积为 0.944(p<0.001)。理想截点为尿量少于 500ml,灵敏度为 90%,特异性为 90.91%。肝移植后严重 AKI 严重影响患者的预后。缺乏呋塞米反应性可快速、准确地预测 AKI 3 期和术后需要 RRT 的患者。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e58/10042839/21f7fd3847b0/41598_2023_31757_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e58/10042839/7b92fd63bbd8/41598_2023_31757_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e58/10042839/98dbbf8de191/41598_2023_31757_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e58/10042839/21f7fd3847b0/41598_2023_31757_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e58/10042839/7b92fd63bbd8/41598_2023_31757_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e58/10042839/98dbbf8de191/41598_2023_31757_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e58/10042839/21f7fd3847b0/41598_2023_31757_Fig3_HTML.jpg

相似文献

1
Lack of furosemide responsiveness predict severe acute kidney injury after liver transplantation.缺乏呋塞米反应预测肝移植后严重急性肾损伤。
Sci Rep. 2023 Mar 27;13(1):4978. doi: 10.1038/s41598-023-31757-8.
2
Lack of Furosemide Responsiveness Predicts Acute Kidney Injury in Infants After Cardiac Surgery.速尿反应性缺乏可预测心脏手术后婴儿的急性肾损伤。
Ann Thorac Surg. 2017 Oct;104(4):1388-1394. doi: 10.1016/j.athoracsur.2017.03.015. Epub 2017 May 9.
3
Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity.速尿应激试验及生物标志物对急性肾损伤严重程度的预测作用
J Am Soc Nephrol. 2015 Aug;26(8):2023-31. doi: 10.1681/ASN.2014060535. Epub 2015 Feb 5.
4
Development and standardization of a furosemide stress test to predict the severity of acute kidney injury.用于预测急性肾损伤严重程度的速尿应激试验的开发与标准化
Crit Care. 2013 Sep 20;17(5):R207. doi: 10.1186/cc13015.
5
[Risk factors analysis of renal replacement therapy after liver transplantation and prognosis effect of initial treatment time].[肝移植术后肾脏替代治疗的危险因素分析及初始治疗时间的预后影响]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1056-1060. doi: 10.3760/cma.j.issn.2095-4352.2018.011.009.
6
Urinary metabolites predict mortality or need for renal replacement therapy after combat injury.尿代谢物可预测战斗损伤后的死亡率或肾脏替代治疗需求。
Crit Care. 2021 Mar 23;25(1):119. doi: 10.1186/s13054-021-03544-2.
7
Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis.速尿应激试验作为急性肾损伤进展或肾脏替代治疗的预测标志物:系统评价和荟萃分析。
Crit Care. 2020 May 7;24(1):202. doi: 10.1186/s13054-020-02912-8.
8
Clinical significance of frusemide stress test in predicting the severity of acute kidney injury.呋塞米应激试验预测急性肾损伤严重程度的临床意义。
J Bras Nefrol. 2021 Oct-Dec;43(4):470-477. doi: 10.1590/2175-8239-JBN-2021-0003.
9
Macrophage migration inhibitory factor as a potential predictor for requirement of renal replacement therapy after orthotopic liver transplantation.巨噬细胞移动抑制因子作为原位肝移植后肾脏替代治疗需求的潜在预测指标。
Liver Transpl. 2015 May;21(5):662-9. doi: 10.1002/lt.24103.
10
Netrin-1 and semaphorin 3A predict the development of acute kidney injury in liver transplant patients.Netrin-1和信号素3A可预测肝移植患者急性肾损伤的发生。
PLoS One. 2014 Oct 7;9(10):e107898. doi: 10.1371/journal.pone.0107898. eCollection 2014.

本文引用的文献

1
Current Concepts of Pediatric Acute Kidney Injury-Are We Ready to Translate Them into Everyday Practice?小儿急性肾损伤的当前概念——我们准备好将其转化为日常实践了吗?
J Clin Med. 2021 Jul 15;10(14):3113. doi: 10.3390/jcm10143113.
2
The furosemide stress test: current use and future potential.速尿激发试验:当前应用和未来潜力
Ren Fail. 2021 Dec;43(1):830-839. doi: 10.1080/0886022X.2021.1906701.
3
Modifiable risk factors of acute kidney injury after liver transplantation: a systematic review and meta-analysis.肝移植后急性肾损伤的可改变危险因素:系统评价和荟萃分析。
BMC Nephrol. 2021 Apr 23;22(1):149. doi: 10.1186/s12882-021-02360-8.
4
Biomarkers for detecting and improving AKI after liver transplantation: From diagnosis to treatment.肝移植后急性肾损伤的检测和改善标志物:从诊断到治疗。
Transplant Rev (Orlando). 2021 Apr;35(2):100612. doi: 10.1016/j.trre.2021.100612. Epub 2021 Mar 5.
5
Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis.速尿应激试验作为急性肾损伤进展或肾脏替代治疗的预测标志物:系统评价和荟萃分析。
Crit Care. 2020 May 7;24(1):202. doi: 10.1186/s13054-020-02912-8.
6
The use of urinary biomarkers to predict acute kidney injury in children after liver transplant.应用尿生物标志物预测肝移植后儿童的急性肾损伤。
Pediatr Transplant. 2020 Feb;24(1):e13608. doi: 10.1111/petr.13608. Epub 2019 Oct 25.
7
The AKI Prediction Score: a new prediction model for acute kidney injury after liver transplantation.AKI 预测评分:肝移植后急性肾损伤的新预测模型。
HPB (Oxford). 2019 Dec;21(12):1707-1717. doi: 10.1016/j.hpb.2019.04.008. Epub 2019 May 29.
8
Urinary and Serum Biomarkers for Prediction of Acute Kidney Injury in Patients Undergoing Liver Transplantation.用于预测肝移植患者急性肾损伤的尿液和血清生物标志物
Ann Transplant. 2019 May 21;24:291-297. doi: 10.12659/AOT.914975.
9
[Risk factors analysis of renal replacement therapy after liver transplantation and prognosis effect of initial treatment time].[肝移植术后肾脏替代治疗的危险因素分析及初始治疗时间的预后影响]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2018 Nov;30(11):1056-1060. doi: 10.3760/cma.j.issn.2095-4352.2018.011.009.
10
Comprehension of Top 200 Prescribed Drugs in the US as a Resource for Pharmacy Teaching, Training and Practice.美国200种常用处方药解读:作为药学教学、培训及实践的资源
Pharmacy (Basel). 2018 May 14;6(2):43. doi: 10.3390/pharmacy6020043.